Establishment of a pharmacokinetic model of exhaled propofol based on real-time monitoring technology of exhaled and blood propofol concentration

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100043243

Enrollment

Unknown

Registered

2021-02-09

Start date

2021-02-18

Completion date

Unknown

Last updated

2021-06-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 18-75 years, elective surgery, and planned general anesthesia.

Exclusion criteria

Exclusion criteria: Fat milk allergy, ASA>=IV.

Design outcomes

Primary

Measure	Time frame
blood concentration;exhaled propofol concentration;	—

Countries

China

Contacts

Public ContactEnyou Li

The First Affiliated Hospital of Harbin Medical University

enyouli@sina.com+86 13845109928

Outcome results